BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

746 related articles for article (PubMed ID: 30244948)

  • 21. Gene microarray analysis of expression profiles in Suberoyllanilide hyroxamic acid-treated Dendritic cells.
    Zhang J; Liu Y; Shi G
    Biochem Biophys Res Commun; 2019 Jan; 508(2):392-397. PubMed ID: 30502083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
    Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
    Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The underlying molecular mechanism and potential drugs for treatment in papillary renal cell carcinoma: A study based on TCGA and Cmap datasets.
    Pang JS; Li ZK; Lin P; Wang XD; Chen G; Yan HB; Li SH
    Oncol Rep; 2019 Apr; 41(4):2089-2102. PubMed ID: 30816528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
    Zhang H; Liu J; Fu X; Yang A
    Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
    Liu X; Liu X; Li J; Ren F
    Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
    Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
    Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of prostate cancer hub genes and therapeutic agents using bioinformatics approach.
    Fang E; Zhang X; Wang Q; Wang D
    Cancer Biomark; 2017 Dec; 20(4):553-561. PubMed ID: 28800317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of Key Genes and miRNAs in Osteosarcoma Patients with Chemoresistance by Bioinformatics Analysis.
    Xie B; Li Y; Zhao R; Xu Y; Wu Y; Wang J; Xia D; Han W; Chen D
    Biomed Res Int; 2018; 2018():4761064. PubMed ID: 29850522
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drug repositioning in head and neck squamous cell carcinoma: An integrated pathway analysis based on connectivity map and differential gene expression.
    Wei GG; Gao L; Tang ZY; Lin P; Liang LB; Zeng JJ; Chen G; Zhang LC
    Pathol Res Pract; 2019 Jun; 215(6):152378. PubMed ID: 30871913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
    Lu C; Chen H; Shan Z; Yang L
    Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid Discovery of Potential Drugs for Osteonecrosis of Femoral Head Based on Gene Expression Omnibus Database and Connectivity Map.
    Luo D; Liang XZ; Xu B; Liu JB; Wei CF; Li G
    Orthop Surg; 2019 Dec; 11(6):1209-1219. PubMed ID: 31692295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Integrated analysis of differentially expressed genes and pathways in triple‑negative breast cancer.
    Peng C; Ma W; Xia W; Zheng W
    Mol Med Rep; 2017 Mar; 15(3):1087-1094. PubMed ID: 28075450
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of Potential Hub Genes and Therapeutic Drugs in Malignant Pleural Mesothelioma by Integrated Bioinformatics Analysis.
    Zhang X; Yang L; Chen W; Kong M
    Oncol Res Treat; 2020; 43(12):656-671. PubMed ID: 33032291
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Gene Changes Induced by Dexamethasone in the Anterior Segment of the Human Eye Using Bioinformatics Analysis.
    Zhang Y; Yang A; Huang J
    Med Sci Monit; 2019 Jul; 25():5501-5509. PubMed ID: 31339875
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression profiles analysis identifies a novel two-gene signature to predict overall survival in diffuse large B-cell lymphoma.
    Sun C; Cheng X; Wang C; Wang X; Xia B; Zhang Y
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30393234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis.
    Fang E; Zhang X
    Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of molecular marker associated with ovarian cancer prognosis using bioinformatics analysis and experiments.
    Zheng MJ; Li X; Hu YX; Dong H; Gou R; Nie X; Liu Q; Ying-Ying H; Liu JJ; Lin B
    J Cell Physiol; 2019 Jul; 234(7):11023-11036. PubMed ID: 30633343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of Key Genes in Colorectal Cancer Regulated by miR-34a.
    Wang T; Xu H; Liu X; Chen S; Zhou Y; Zhang X
    Med Sci Monit; 2017 Dec; 23():5735-5743. PubMed ID: 29197895
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.